RDC

Avicanna Reports Full Year 2023 Audited Financial Results 

Retrieved on: 
Tuesday, April 2, 2024
Cream, Cannabidiol, Cannabinoid, Dravet syndrome, Brazilian Health Regulatory Agency, Interest, Medical cannabis, Seizure, Business, Lennox–Gastaut syndrome, Patient, Pharmacy, Active ingredient, Research, Acquisition, RDC, Ultra, Stock, CBD, Insurance, Health Canada, Bank statement, GMP, Dermatology, TSX, Therapy, Pharmaceutical industry

TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce year end 2023 results and audited financial statements.

Key Points: 
  • TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce year end 2023 results and audited financial statements.
  • Cash used in operations of $1.38 million; an 81% reduction compared to $7.4 million in 2022.
  • “2023 was a tremendous year for Avicanna where we solidified of our leadership position in the Canadian medical cannabis sector through our proprietary products and the launch of MyMedi.ca.
  • We have successfully demonstrated the scalability of our revenues and made significant improvements in our fundamentals while advancing all our business pillars.

Clever Leaves Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Monday, April 1, 2024
Financial statement, Certification, HBI, Consolidated, Partnership, Accounting Standards Codification, Patient, Sale, RDC, Sales, Closing, GMP, Procurement, ASC, Traction, Interest, ATM, Security, Note, Investment, THC, Pharmaceutical industry

TOCANCIPÁ, Colombia, April 01, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, is reporting financial and operating results for the fourth quarter and full year ended December 31, 2023. All financial information is provided in US dollars unless otherwise indicated.

Key Points: 
  • Subsequent to the end of the fourth quarter, we completed the $1.5 million sale of our Portuguese farm assets.
  • As we progress into 2024, we remain focused on driving further capital preservation and operational efficiencies.”
    Fourth Quarter 2023 Summary vs.
  • Same Year-Ago Quarter1
    Revenue in the fourth quarter of 2023 increased 5% to $4.6 million compared to $4.4 million for the same period in 2022.
  • Net loss in 2023 includes a $3.7 million loss on investment related to the fourth quarter sale of the Company’s remaining Cansativa stake.

QYOU Expands Connected TV and QPlay+ Via Major New Channel and Distribution Partnerships

Retrieved on: 
Wednesday, March 27, 2024
GameX, Pluto, Marvel, Connected, Growth, Smart TV, Partnership, Paramount, Social media, RDC, Animation, Samsung, Roku, Sadhguru, Catalog, Hindi cinema, FAST, BBC, CTV, Vizio

QYOU Media India's growing portfolio of seven FAST (Free Ad Supported TV) CTV channels - now includes: The Q, The Q Kahaniyan, Q GameX, Sadhguru TV, Bollywood Hungama, QToonz and RDCMovies.

Key Points: 
  • QYOU Media India's growing portfolio of seven FAST (Free Ad Supported TV) CTV channels - now includes: The Q, The Q Kahaniyan, Q GameX, Sadhguru TV, Bollywood Hungama, QToonz and RDCMovies.
  • The Connected TV (CTV) business in both India and globally continues to grow at an unprecedented rate with 9 out of 10 TV's sold in India last year being Smart TV's.
  • We are at the very beginning of this same shift in India and it is critical to get early channel distribution and positioning.
  • We will continue to grow our channel assets with unique and strong content partners like Toonz and RDC movies alongside our previous partnerships with major partners including Sadhguru.

Receipts Depositary Corporation (RDC) Appoints Scott Pollak Head of Strategy and Capital Markets

Retrieved on: 
Tuesday, March 12, 2024
Bitcoin, American depositary receipt, Quinnipiac University, Accounting, DTC, CUSIP, Capital market, Citigroup, Head, Depository Trust Company, Growth, Entrepreneurship, BTC, RDC, Security (finance)

NEW YORK, March 12, 2024 /PRNewswire/ -- Receipts Depositary Corporation (RDC) today announced the appointment of Scott Pollak as Head of Strategy and Capital Markets. Pollak joins following RDC's launch earlier this year and is the former managing director and global head of depositary receipts at Citi. 

Key Points: 
  • NEW YORK, March 12, 2024 /PRNewswire/ -- Receipts Depositary Corporation (RDC) today announced the appointment of Scott Pollak as Head of Strategy and Capital Markets.
  • Pollak joins following RDC's launch earlier this year and is the former managing director and global head of depositary receipts at Citi.
  • He spent over 14 years in a variety of leadership positions at Citi's depositary receipts business, most recently as its global leader.
  • "Depositary receipts provide institutional buyers with a tried and tested solution that makes it as easy to own digital and alternative assets as any traditional security," said Scott Pollak.

Next-Generation Safety: Radiation Detection Company Announces Availability of New Bluetooth Digital Dosimeter to Eliminate Shipping Exchanges and Improve Dose Visibility

Retrieved on: 
Friday, March 1, 2024
Health, Medical Devices, Technology, Hospitals, Health Technology, Mobile, Wireless, Radiology, Partnership, Thermo Fisher Scientific, RDC, Bluetooth, Human, ALARA, Medical imaging

NetDose’s digital technology offers real time radiation monitoring using Bluetooth technology, eliminating the need to ship dosimeters back and forth to a laboratory for processing.

Key Points: 
  • NetDose’s digital technology offers real time radiation monitoring using Bluetooth technology, eliminating the need to ship dosimeters back and forth to a laboratory for processing.
  • The combination of leading technology from Thermo Fisher and 75 years of dosimetry service experience from RDC is sure to deliver incredible value for our customers,” said Ryan Turk, CEO, Radiation Detection Company.
  • “My thorough testing of the NetDose device has left me impressed by its exceptional reproducibility and precision.
  • With a detection limit reaching below 1 mrem, the NetDose dosimeter stands as a true technological advancement, transforming the landscape of external radiation dosimetry in ways unparalleled in the market,” said Chris Passmore, CTO, Radiation Detection Company.

Managing the transition to central bank digital currency

Retrieved on: 
Wednesday, February 14, 2024
Technical report, Regulation, Private sector, Aircraft, Interest, RTD, Policy, CES, Research Papers in Economics, A.2, The Economic Journal, RTK, International Settlement, F30, Next, A.6, Community business development corporation, A.7, UIP, American Economic Journal, National bank, Paper, Bank, Macroeconomics, Economy, Central bank, GSS, Capital, XF, Elasticity, Government, Competition, Credit, Social science, Volatility, Domestic, European, IH, Investment, A.13, SSRN, Intermediate, A.5, Section 2, AP, Probability, Review of Economic Dynamics, Foreign, Journal of Monetary Economics, Remuneration, Uncertainty, Medical classification, Bank of England, Shock, DF, Bank of Canada, ISSN, CIA, European Central Bank, Survival, RD, FH, KT, N B, Cuore, Monetary economics, Section 3, Welfare, Iteration, DSGE, Blessthefall, Reserve, Website, GBP, Calibration, RDC, Parameter, DCT, GDP, KF, Sokol, Rebelo, Figure, De Nederlandsche Bank, Parity, TFP, Depreciation, Total, BIS, Home, Section 4, Attitude, Acquisition, JEL, Cross, Household, FF, QT, Control, Swiss, Motion, ECB, M. A, GF, A.9, RT, Cattolica, Exercise, C.2, XH, Tax, Crowding, European Parliament, Literature, Reproduction, Political economy, Committee, Exp, E50, Uhlig, EUR, IID, Digital currency, Tourism, American Economic Review, Manuscript, AG, A.8, Research, F41, Friction, Public sector, PDF, U N, YH, Cryptocurrency
Key Points: 

    A Collaborative of San Diego Design Leaders Reinvigorates the Design Center, Introduces Futuro Space

    Retrieved on: 
    Tuesday, February 6, 2024
    Glass, SAN, Century, Transport, World Design Capital, California Department of Transportation, Senior, Fifth Avenue, California Department, History, Community, RDC, Balboa Park, FAIA, Collection, Futuro, AIA, ASLA, Built environment, City, State highway, C-3, Creativity, State, Architecture, American Institute, Urban Land Institute, PLA, Organization

    “The San Diego Design Center is not just a building, but a place where history and creativity meet,” said Sean Slater, AIA, Senior Principal at RDC.

    Key Points: 
    • “The San Diego Design Center is not just a building, but a place where history and creativity meet,” said Sean Slater, AIA, Senior Principal at RDC.
    • Groups Futuro has hosted include the Urban Land Institute (ULI San Diego-Tijuana), the American Institute of Architects (AIA San Diego), the San Diego Architectural Foundation, and Citizens Coordinate for Century 3 (C-3).
    • Futuro Space is currently working with World Design Capital San Diego-Tijuana to discuss strategies for the World Design Capital 2024 celebration events.
    • “The recent selection of San Diego as the World Design Capital adds an additional layer of importance to the activities at the Design Center and the launch of Futuro Space,” Slater said.

    Avicanna and Ease Labs Pharma Granted Commercialization Approval for Pharmaceutical Preparation in Brazil

    Retrieved on: 
    Tuesday, January 30, 2024
    Aureus, THC, RDC, Patient, SAS, TSX, CBD, Entrepreneurship, API, ANVISA, Trust, GMP, Pharmacy, Pharmaceutical industry

    TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce ANVISA has granted commercialization approval of Ease Labs Pharma (“Ease Labs”) pharmaceutical preparation produced in Brazil containing Avicanna’s Aureus branded active pharmaceutical ingredient (“API”).

    Key Points: 
    • TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce ANVISA has granted commercialization approval of Ease Labs Pharma (“Ease Labs”) pharmaceutical preparation produced in Brazil containing Avicanna’s Aureus branded active pharmaceutical ingredient (“API”).
    • Ease Labs, a GMP-certified pharmaceutical company in Brazil, was granted approval from ANVISA to commercialize a pharmaceutical preparation product containing 2.5% of CBD and up-to 0.2% THC.
    • This is the first product containing THC granted sanitary authorization under the RDC 327 and GMP certified manufacturing standards in Brazil.
    • Ease Labs expects the product to be available in pharmacies with a medical prescription by March 2024.

    National Geospatial-Intelligence Agency Awards IDIQ Research and Development Contract with $794 Million Ceiling to Solis Applied Science Team, Including Sidus Space

    Retrieved on: 
    Friday, February 2, 2024
    Technology, Research, Engineering, Satellite, Aerospace, Manufacturing, Hardware, Other Science, Science, RDC, IDIQ, NGA, Development

    Sidus Space (NASDAQ: SIDU) (the “Company” or “Sidus”), a multi-faceted Space and Data-as-a-Service satellite company is proud to announce it is a member of the Solis Applied Science, LLC Team which was selected by the National Geospatial-Intelligence Agency's (NGA) to provide research and development services to NGA’s Research and Development directorate.

    Key Points: 
    • Sidus Space (NASDAQ: SIDU) (the “Company” or “Sidus”), a multi-faceted Space and Data-as-a-Service satellite company is proud to announce it is a member of the Solis Applied Science, LLC Team which was selected by the National Geospatial-Intelligence Agency's (NGA) to provide research and development services to NGA’s Research and Development directorate.
    • The NGA awarded the Research and Development Contract (RDC) indefinite-delivery, indefinite-quantity (IDIQ) contract on January 25, 2024, to Solis Applied Science, LLC, one of four IDIQ awardees.
    • "The opportunity to contribute to NGA's Research and Development Contract aligns seamlessly with Sidus Space's commitment to pushing the boundaries of space technology and data services," said Carol Craig, CEO of Sidus Space.
    • For more information on the NGA's $794 million Research and Development Contract, view NGA’s official announcement here .

    Digital Check’s TellerScan, CheXpress Scanners Now Support macOS 14 “Sonoma”

    Retrieved on: 
    Thursday, January 4, 2024
    Apple M1, Digital, Small business, API, DCC, RDC, Apple, M1, Mac, Engineering, MacOS, Television

    Northbrook, IL, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Digital Check Corp., the world’s leading manufacturer of desktop check scanners, has added native support for Apple’s macOS 14 “Sonoma” to two of its most popular scanner models.

    Key Points: 
    • Northbrook, IL, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Digital Check Corp., the world’s leading manufacturer of desktop check scanners, has added native support for Apple’s macOS 14 “Sonoma” to two of its most popular scanner models.
    • The TellerScan TS240 and CheXpress CX30 scanners, with a global install base of over 1 million devices, will now offer native support for macOS 14 when used with the latest version of the Digital Check API (DCC API).
    • This brings the company’s two highest-selling scanner models current with the most recent Mac operating system launched in September 2023.
    • Digital Check plans to include support for all new major releases of macOS in the future.